Danaher Net Worth 2010-2025 | DHR

Interactive chart of historical net worth (market cap) for Danaher (DHR) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Danaher net worth as of July 18, 2025 is $139.41B.
Sector Industry Market Cap Revenue
Medical Medical Services $139.405B $23.875B
Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally.
Stock Name Country Market Cap PE Ratio
CVS Health (CVS) United States $80.076B 9.95
Elevance Health (ELV) United States $68.334B 9.16
Cencora (COR) United States $57.058B 19.85
DiDi Global (DIDIY) China $27.204B 28.90
Labcorp Holdings (LH) United States $20.694B 16.78
Natera (NTRA) United States $19.578B 0.00
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.895B 0.00
CochLear (CHEOY) Australia $13.107B 0.00
Solventum (SOLV) United States $12.779B 13.53
ICON (ICLR) Ireland $11.862B 11.03
Revvity (RVTY) United States $11.266B 19.39
Viatris (VTRS) United States $10.880B 3.74
Medpace Holdings (MEDP) United States $9.173B 24.36
Avantor (AVTR) United States $9.056B 13.16
Sonic Healthcare (SKHHY) Australia $8.822B 0.00
HealthEquity (HQY) United States $8.658B 37.92
Caris Life Sciences,�Inc (CAI) United States $7.959B 0.00
Charles River Laboratories (CRL) United States $7.696B 15.08
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $5.017B 29.54
BrightSpring Health Services (BTSG) United States $3.534B 32.42
Sotera Health (SHC) United States $3.188B 18.11
Surgery Partners (SGRY) United States $2.899B 37.70
Alignment Healthcare (ALHC) United States $2.602B 0.00
Concentras Parent (CON) United States $2.533B 14.64
Organon (OGN) United States $2.506B 2.66
GeneDx Holdings (WGS) United States $2.295B 88.37
Progyny (PGNY) United States $1.972B 43.42
PACS (PACS) United States $1.876B 0.00
Premier (PINC) United States $1.735B 13.17
GoodRx Holdings (GDRX) United States $1.689B 33.79
Ardent Health (ARDT) United States $1.656B 7.06
Teladoc Health (TDOC) United States $1.410B 0.00
QDM (QDMI) Hong Kong, SAR China $1.277B 438.00
Establishment Labs Holdings (ESTA) $1.228B 0.00
Pediatrix Medical (MD) United States $1.103B 8.39
Ryman Healthcare (RYHTY) New Zealand $0.970B 0.00
Agilon Health (AGL) United States $0.898B 0.00
AMN Healthcare Services Inc (AMN) United States $0.779B 7.29
CareDx (CDNA) United States $0.658B 10.27
Nutex Health (NUTX) United States $0.615B 9.32
Embecta (EMBC) United States $0.576B 3.88
InnovAge Holding (INNV) United States $0.571B 0.00
SBC Medicals (SBC) United States $0.569B 0.00
So-Young (SY) China $0.507B 0.00
LifeMD (LFMD) United States $0.504B 0.00
Sonida Senior Living (SNDA) United States $0.476B 0.00
Auna S.A (AUNA) Luxembourg $0.474B 10.68
Omada Health (OMDA) $0.456B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.363B 0.00
Enhabit (EHAB) United States $0.337B 27.75
Oncology Institute (TOI) United States $0.326B 0.00
Performant Healthcare (PHLT) United States $0.315B 0.00
Beauty Health (SKIN) United States $0.209B 0.00
DocGo (DCGO) United States $0.148B 24.17
Pheton Holdings (PTHL) China $0.143B 0.00
Sera Prognostics (SERA) United States $0.113B 0.00
Ascend Wellness Holdings (AAWH) United States $0.078B 0.00
KindlyMD (NAKA) United States $0.069B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.059B 0.00
Basel Medical Group (BMGL) Singapore $0.052B 0.00
Biodesix (BDSX) United States $0.046B 0.00
ModivCare (MODV) United States $0.044B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.038B 0.00
OSR Holdings (OSRH) United States $0.019B 0.00
Intelligent Bio Solutions (INBS) United States $0.015B 0.00
BioNexus Gene Lab (BGLC) $0.012B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
SeaStar Medical Holding (ICU) United States $0.007B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00